Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
SN-38 Disrupts FUBP1–FUSE Binding in Cancer Cells
2026-09-30
The reference study identified camptothecin and SN-38 as inhibitors of the FUBP1–FUSE DNA interaction, revealing a regulatory mechanism beyond their established topoisomerase I activity. Its findings support testing FUBP1-dependent transcription alongside DNA damage, apoptosis, and cell-cycle endpoints in carefully matched cancer models.
-
Cy5 Goat Anti-Mouse IgG (H+L) for Vaccine Assays
2026-09-30
Explore how the Cy5 Goat Anti-Mouse IgG (H+L) Antibody can connect ferritin-based vaccine research with rigorous fluorescent endpoint design. This article translates particle-immunology findings into practical choices for mouse IgG detection, multiplexing, and assay validation.
-
ABT-888 (Veliparib) DNA Repair Workflow
2026-09-29
ABT-888 (Veliparib) is a selective PARP1/2 inhibitor for building DNA damage-response, chemotherapy-sensitization, and radiation-response assays. This guide connects practical dosing and assay controls with colorectal cancer models and the biomarker-led CHK1 research landscape.
-
IL-2 Human Recombinant: Mechanism and Workflow
2026-09-29
IL-2, human recombinant is a research cytokine for studying interleukin-2 receptor signaling in receptor-competent cells. The cited FUS–SMN study establishes a separate neuronal phase-separation mechanism and does not demonstrate that IL-2 modulates neuronal granules.
-
γH2AX DNA Damage Detection Kit for DSB Research
2026-09-28
Translate radiation, nanoparticle, and genotoxicity experiments into measurable nuclear γ-H2AX signals with a red-fluorescence workflow suited to microscopy and high-content screening. This guide combines practical assay setup, treatment-specific controls, and troubleshooting for reproducible DNA double-strand break detection.
-
Carvacrol in TRPA1 Redox-Sensing Workflows
2026-09-28
Use Carvacrol as a non-electrophilic TRPA1 agonist to test channel function after oxidative challenge—not as a substitute for a reactive oxygen species. This workflow separates acute ion-channel readouts from Carvacrol’s distinct cell-cycle and apoptosis research applications, with practical controls for each.
-
Topotecan HCl Workflows for Cancer Assays
2026-09-27
Use Topotecan HCl to study replication-linked DNA damage while separating growth arrest from actual cell killing. Model-specific concentration and exposure windows, paired with distinct response readouts, make its cancer-assay results more interpretable.
-
Amikacin Sulfate Workflows for NTM Research
2026-09-26
Pair extracellular CFU measurements with intracellular dendritic-cell assays to distinguish Amikacin activity from delivery and cell-response effects. This workflow also shows how kidney-safety context can inform interpretation without implying an unproven interaction between nicotine exposure and amikacin.
-
Cy3 TSA Fluorescence System Kit: Cancer Research
2026-09-25
The Cy3 TSA Fluorescence System Kit uses HRP-catalyzed tyramide deposition to amplify fluorescence microscopy detection in IHC, ICC, and ISH. It can support detection of low-abundance biomolecules, but it does not replace target-specific probes, antibodies, or assay validation.
-
TCF25 Links Glucose Sensing to Lysosomal Cell Death
2026-09-25
A genome-wide CRISPR-Cas9 screen identifies TCF25 as a regulator that helps cells adapt to glucose deprivation by enhancing V-ATPase-dependent lysosomal acidification. With prolonged starvation, the same pathway promotes ferritinophagy and lysosome-dependent cell death, while TCF25 deficiency protects mice in a hepatic ischemia-reperfusion model.
-
E-4031 for 3D Cardiac Electrophysiology Research
2026-09-24
Pair E-4031-mediated hERG blockade with shell microelectrode arrays to test how delayed repolarization changes electrical wave propagation across cardiac organoids—not just activity at a planar contact surface. This workflow combines a controlled dose-response, spatial mapping, and calcium-imaging validation while flagging key limits in interpreting proarrhythmic phenotypes.
-
Genotyping Kit for target alleles: PCR workflows
2026-09-24
See how single-tube DNA preparation can simplify PCR genotyping across insects, tissues, fish, and cells—without phenol/chloroform extraction or a separate DNA column. The workflow also clarifies where rapid allele genotyping can support mechanistic studies, and where expression assays are still required.
-
Staurosporine and the Cell-Death-to-Metastasis Paradox
2026-09-23
Staurosporine is a broad-spectrum serine/threonine protein kinase inhibitor used to probe apoptosis and kinase signaling. This article explains how to design experiments that distinguish cell killing from the prometastatic states that may emerge in cells surviving near-death stress.
-
Carboplatin Workflows for Cancer Research
2026-09-23
Build reproducible Carboplatin dose-response, resistance, combination, and xenograft workflows with formulation-aware controls. This practical guide connects ovarian and lung cancer models to clinically informed endpoint selection without overstating what preclinical data can prove.
-
Amikacin Sulfate: From Ribosome to Granuloma
2026-09-22
Amikacin Sulfate offers a useful translational model for connecting ribosomal bactericidal activity with intracellular and granuloma-focused exposure. This article examines how researchers can move beyond simple potency claims by integrating assay context, functional selection logic, targeted delivery, and therapeutic-index strategy.